Comparison of clinical indices and models based on MTV and MH
| . | . | PFS . | OS . | ||
|---|---|---|---|---|---|
| . | Prognostic model . | AIC . | CPE . | AIC . | CPE . |
| Testing set | MTV dichotomized | 265 | 0.6436 (±0.0433) | 207 | 0.6847 (±0.0440) |
| MTV+MH model | 260 | 0.6684 (±0.0440) | 201 | 0.7065 (±0.0443) | |
| IPI | 273 | 0.5908 (±0.0513) | 215 | 0.6086 (0.0584) | |
| R-IPI | 272 | 0.5908 (±0.0498) | 214 | 0.6175 (±0.0564) | |
| NCCN-IPI | 272 | 0.5857 (±0.0511) | 211 | 0.6409 (±0.0578) | |
| Validation set | MTV dichotomized | 192 | 0.6356 (±0.0556) | 162 | 0.6346 (±0.0607) |
| MTV+MH model | 186 | 0.6944 (±0.0586) | 156 | 0.6884 (±0.0638) | |
| IPI | 194 | 0.6143 (±0.0613) | 165 | 0.6171 (±0.0668) | |
| R-IPI | 196 | 0.5586 (±0.0556) | 166 | 0.5933 (±0.0606) | |
| NCCN-IPI | 196 | 0.5729 (±0.0592) | 164 | 0.6150 (±0.646) | |
| . | . | PFS . | OS . | ||
|---|---|---|---|---|---|
| . | Prognostic model . | AIC . | CPE . | AIC . | CPE . |
| Testing set | MTV dichotomized | 265 | 0.6436 (±0.0433) | 207 | 0.6847 (±0.0440) |
| MTV+MH model | 260 | 0.6684 (±0.0440) | 201 | 0.7065 (±0.0443) | |
| IPI | 273 | 0.5908 (±0.0513) | 215 | 0.6086 (0.0584) | |
| R-IPI | 272 | 0.5908 (±0.0498) | 214 | 0.6175 (±0.0564) | |
| NCCN-IPI | 272 | 0.5857 (±0.0511) | 211 | 0.6409 (±0.0578) | |
| Validation set | MTV dichotomized | 192 | 0.6356 (±0.0556) | 162 | 0.6346 (±0.0607) |
| MTV+MH model | 186 | 0.6944 (±0.0586) | 156 | 0.6884 (±0.0638) | |
| IPI | 194 | 0.6143 (±0.0613) | 165 | 0.6171 (±0.0668) | |
| R-IPI | 196 | 0.5586 (±0.0556) | 166 | 0.5933 (±0.0606) | |
| NCCN-IPI | 196 | 0.5729 (±0.0592) | 164 | 0.6150 (±0.646) | |